HT90432
Safranin O solution
Iniciar sesión para ver los precios por organización y contrato.
Seleccione un Tamaño
Cambiar Vistas
Acerca de este artículo
NACRES:
NA.47
UNSPSC Code:
41116121
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarleform
solution
Quality Level
shelf life
Expiry date on the label
IVD
for in vitro diagnostic use
concentration
0.6%
pH
8.5
application(s)
hematology
histology
storage temp.
room temp
Application
Intended for use in Sigma Gram Stain Procedure, HT90.
Other Notes
Certified safranin 0.6% in 20% ethyl alcohol, SD3A.
signalword
Warning
hcodes
Hazard Classifications
Flam. Liq. 3
Clase de almacenamiento
3 - Flammable liquids
wgk
WGK 2
flash_point_f
100.0 °F - closed cup
flash_point_c
37.8 °C - closed cup
ppe
Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter
Elija entre una de las versiones más recientes:
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
Hye Jin Kim et al.
Biomaterials, 177, 1-13 (2018-06-09)
Overexpression and knockdown of specific proteins can control stem cell differentiation for therapeutic purposes. In this study, we fabricated RUNX2, SOX9, and C/EBPα plasmid DNAs (pDNAs) and ATF4-targeting shRNA (shATF4) to induce osteogenesis, chondrogenesis, and adipogenesis of human mesenchymal stem
Inhibition of integrative repair of the meniscus following acute exposure to interleukin-1 in vitro.
Rebecca E Wilusz et al.
Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 26(4), 504-512 (2007-12-01)
Damage or loss of the meniscus is associated with progressive osteoarthritic degeneration of the knee joint. Injured and degenerative joints are characterized by elevated levels of the pro-inflammatory cytokine interleukin-1 (IL-1), which with prolonged exposure can induce catabolic and anti-anabolic
Melissa N van Tok et al.
Arthritis & rheumatology (Hoboken, N.J.), 71(4), 612-625 (2018-11-06)
It remains unclear if and how inflammation and new bone formation in spondyloarthritis (SpA) are coupled. We undertook this study to assess the hypothesis that interleukin-17A (IL-17A) is a pivotal driver of both processes. The effect of tumor necrosis factor